Display Settings:

Format

Send to:

Choose Destination

    Science. 1990 Dec 21;250(4988):1707-8.

    Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome.

    Mayeno AN, Lin F, Foote CS, Loegering DA, Ames MM, Hedberg CW, Gleich GJ.

    Epidemiologic studies strongly associate eosinophilia-myalgia syndrome (EMS) with ingestion of tryptophan containing a contaminant ("peak E"). Prior reports have suggested that peak E is the di-tryptophan N alpha-animal of acetaldehyde. Spectral and chemical studies now demonstrate that peak E is 1,1'-ethylidenebis[tryptophan]. This novel amino acid may be the etiological agent responsible for EMS, or it may be a marker of a still unidentified causal agent.

    PMID: 2270484 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read